RecruitingPHASE1, PHASE2NCT05937191
Leflunomide for Idiopathic Pulmonary Hemosiderosis in Children
Studying Idiopathic pulmonary hemosiderosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Intervention
- Leflunomide(drug)
- Enrollment
- 34 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2026
Study locations (1)
- Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05937191 on ClinicalTrials.gov